Tag: 194M

share on FacebookShare TwitterBy Mary Vanac | Cleveland Business JournalCleveland Diagnostics Inc. raised $ 19.4 million to help commercialize its first diagnostic test to detect early-stage prostate cancer.The clinical-stage biotechnology company, which develops diagnostic tests for the early detection of cancer, has completed a Series D round of...